Clinical Trial Update: A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing the effects of fasting duration and withholding tirzepatide on the amount of food and fluid in the stomach in participants with T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2, Overweight | Phase 1 | Status: RECRUITING